Jfl Life Sciences share news, announcements and annual reports
NSE: JFLLIFEPharmaceuticals & Biotechnology
Share price at the NSE close on 29 Oct 2026. Previous close ₹10.00.
29 Oct: open ₹9.75, high ₹9.80, low ₹9.70
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹32 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 4.77
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.70
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 15.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 18,000100.0% delivered
Jfl Life Sciences share news and announcements
159 announcements, routine notices left out, newest first. Page 2 of 4.
May 2025
19 May · Board meeting
11 May · General Updates
11 May · Board meeting
Apr 2025
22 Apr · Board meeting
9 Apr · Board meeting
8 Apr · Board meeting
Mar 2025
27 Mar · Board meeting
Feb 2025
28 Feb · Legal
28 Feb
11 Feb · Legal
Jan 2025
Nov 2024
14 Nov · Board meeting
14 Nov · Board meeting
14 Nov · Results
Oct 2024
7 Oct · Updates
4 Oct · General Updates
4 Oct · Board meeting
Sep 2024
23 Sep · Dividend
23 Sep · General Updates
10 Sep · Updates
10 Sep · Corporate action
Aug 2024
31 Aug · Updates
31 Aug · Board meeting
31 Aug · Dividend
31 Aug · Corporate action
31 Aug · Board meeting
2 Aug · Updates
2 Aug · Increase in Authorised Capital
2 Aug · Board meeting
Jul 2024
26 Jul · Board meeting